Are the oncological results of laparoscopic nephroureterectomy for upper urinary tract transitional cell cancer equal to those of open nephroureterectomy?
Oncological results of LNU and ONU are comparable. The lower morbidity of LNU offers advantages for the patient.
Treatment of advanced, recurrent, refractory epithelial ovarian cancer with bevacizumab and weekly taxane chemotherapy leads to significant, albeit temporary, improvement in the cancer-related symptoms in women treated on this regimen, and short-term exposure to these agents is not associated with significant toxicity. Thus, continued investigation of bevacizumab with weekly scheduling of cytotoxic chemotherapy is imperative.